We publish this in full from shares and shares  media outlet “Stockhead”

Compass Cannabis launched two clinics in Australia final 12 months and is now prepping for an fairness crowdfunding marketing campaign on Birchal in July.
We be taught that head honcho Dave Martyn is even planning to maneuver to Australia
“I believe Australia and New Zealand are the best international markets outside North America in terms of growth. Both have flown under the radar because of COVID-19 and because they’re still early stage, but the near-term catalysts are here,” Martyn, president of Compass Cannabis, instructed Stockhead.

Has our mate Dave ever handled Australian state and federal politicians?

Does he realise that though there are a slowly rising variety of medicinal cannabis sufferers in Australia we concur along with his evaluation there . At the velocity Australia is going they’ll have the similar quantity of medical sufferers as  Canada or the USA (% in comparison with poulation)  someday in the 23rd century.

Nevermind…. an undereducated medical neighborhood on medical cannabis who additionally occur to be extemely conservative about change.

We may go on.. however we predict you would possibly get the message by now.

Dave could properly have had a some vactions in Australia, he properly have a few clinics and many others however until he is very properly politically linked it’ll all come to naught over time.

Also Dave..  beware pleasant Aussie mates bearing presents. They aren’t as pleasant as you suppose and also you’ll by no means break into their Aussie mateship circle. It simply doesn’t occur, even when they’re making a living out of you!

 

The Report

Special Report: Compass Cannabis is doubling down on Australia, which it says is the fastest growing medicinal cannabis market in the world.  

Over the final 12 months the Australian cannabis market has been marked by overseas pot shares fleeing their investments right here, however one worldwide firm has chosen to double down.

Canadian affected person entry enterprise Compass Cannabis launched two clinics in Australia final 12 months and is now prepping for an fairness crowdfunding marketing campaign on Birchal in July.

If that isn’t severe sufficient, boss Dave Martyn is even planning to maneuver right here.

“I believe Australia and New Zealand are the best international markets outside North America in terms of growth. Both have flown under the radar because of COVID-19 and because they’re still early stage, but the near-term catalysts are here,” Martyn, president of Compass Cannabis, instructed Stockhead.

Compass Cannabis is a clinic enterprise, with two in NSW and 5 in Canada.

In Australia it has a partnership with Medipharm Labs to produce white labelled merchandise to be resold in the clinic mannequin, and with Medigrowth in New Zealand.

Martyn’s plans for Australia embody a clinic in Melbourne, a hotspot location for medical cannabis corporations, and the bodily clinic community extra broadly.

The firm additionally has a telemedicine and digital well being service — know-how that has been in scorching demand since the COVID-19 pandemic compelled the world to stay in their properties.

“We have been using telemedicine in both Canada and Australia since the pandemic started, with quickly growing numbers of patients. However, the goal is to expand our reach and capabilities as patient demand for these services continues to increase,” he stated.

 

Australia is the cannabis development capital of the world

They selected Australia over different development markets like Germany, the UK and the US due to big development in affected person numbers month-on-month.

Having labored in a wide range of jurisdictions, Martyn additionally says Australia’s cannabis regulatory processes are a few of the most enterprise pleasant in the world. The potential reclassification of cannabidiol (CBD) in February subsequent 12 months is additionally very constructive.

For New Zealand, the potential is if grownup cannabis use is legalised in September, opening the door to a cannabis tourism increase much like that seen in Colorado and Oregon in the US.

“We’ve really looked hard at different regions, but Australia was the one we really found had the potential,” Martyn stated.

“In 2018, when we first arrived, it was very early in the business cycle. Where we see it sitting today, well I suspect cannabis is Australia’s fastest growing industry.”

Patient entry numbers have set new month-to-month data in 9 of the previous 13 months and May was the first month with over 4000 authorisations to be used. For perspective, in all of 2017, the 12 months after legalisation, there have been round 250 approvals given for the 12 months.

“We don’t see that number slowing. It’s already exceeding the early Canadian patient figures which were 7900 after 13 years in 2014,” Martyn stated.

Over 15,000 prescriptions have been authorized final 12 months and estimates for 2020 begin anyplace round 70,000 — that’s the Department of Health’s expectation offered to a Senate committee — to 140,000 in response to information analytics agency Fresh Leaf Analytics.

 

Funding development

Compass Cannabis is not wanting money for its development plans. A retail division known as Starbuds International, named Canada’s startup of the 12 months in 2019, was bought in April for $14m.

However, the firm desires to align its enterprise with Aussie retail traders and desires a bit additional in the kitty to fund development in a number of completely different areas.

Martyn is targeting retail investors via Birchal because, as in Canada, they’ve been the earliest backers of medical cannabis with establishments {and professional} traders coming into later.

“Australia is a market we have funded out of our own pocket since 2018. We’ve had some good success — we have a couple of clinics here and patient growth is very strong — and now we better understand the market and where it’s going we want to expand,” Martyn stated.

“We see significant opportunities in advising patients on medical cannabis, and around importing and selling products. We are also looking for funding to expand our telemedicine and virtual health system in Canada and Australia. With COVID-19 keeping everyone at home, it feels like a great time to do this.”

The plan contains having merchandise, each dried flower and oils, out there for the extremely anticipated CBD reclassification, which will see merchandise that don’t include THC moved from the Special Access Scheme prescription-only mannequin to out there over the counter in pharmacies.

Australia is the next big growth market: Compass Cannabis

Source link